Obesidad, adipogénesis y resistencia a la insulina
Tóm tắt
Từ khóa
Tài liệu tham khảo
Mokdad, 2001, The continuing epidemics of obesity and diabetes in the United States, Jama, 286, 1195, 10.1001/jama.286.10.1195
Facchini, 2001, Insulin resistance as a predictor of age-related diseases, J Clin Endocrinol Metab, 86, 3574, 10.1210/jc.86.8.3574
Reaven, 2005, The insulin resistance syndrome: definition and dietary approaches to treatment, Annu Rev Nutr, 25, 391, 10.1146/annurev.nutr.24.012003.132155
Grant, 2006, Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes, Nat Genet, 38, 320, 10.1038/ng1732
Voight, 2010, Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis, Nat Genet, 42, 579, 10.1038/ng.609
Speliotes, 2010, Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index, Nat Genet, 42, 937, 10.1038/ng.686
Heid, 2010, Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution, Nat Genet, 42, 949, 10.1038/ng.685
Meyre, 2009, Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations, Nat Genet, 41, 157, 10.1038/ng.301
Scherag, 2010, Two new Loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and german study groups, PLoS Genet, 6, e1000916, 10.1371/journal.pgen.1000916
Thorleifsson, 2009, Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity, Nat Genet, 41, 18, 10.1038/ng.274
Willer, 2009, Six new loci associated with body mass index highlight a neuronal influence on body weight regulation, Nat Genet, 41, 25, 10.1038/ng.287
Schenk, 2008, Insulin sensitivity: modulation by nutrients and inflammation, J Clin Invest, 118, 2992, 10.1172/JCI34260
Ogawa, 1998, Role of binding proteins to IRS-1 in insulin signalling, Mol Cell Biochem, 182, 13, 10.1023/A:1006862807598
Accili, 1996, Early neonatal death in mice homozygous for a null allele of the insulin receptor gene, Nat Genet, 12, 106, 10.1038/ng0196-106
Joshi, 1996, Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality, Embo J, 15, 1542, 10.1002/j.1460-2075.1996.tb00498.x
Shirakami, 2002, Heterozygous knockout of the IRS-1 gene in mice enhances obesity-linked insulin resistance: a possible model for the development of type 2 diabetes, J Endocrinol, 174, 309, 10.1677/joe.0.1740309
Kriauciunas, 2000, Cellular compartmentalization in insulin action: altered signaling by a lipid-modified IRS-1, Mol Cell Biol, 20, 6849, 10.1128/MCB.20.18.6849-6859.2000
Saltiel, 2001, Insulin signalling and the regulation of glucose and lipid metabolism, Nature, 414, 799, 10.1038/414799a
Araki, 1994, Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene, Nature, 372, 186, 10.1038/372186a0
Tamemoto, 1994, Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1, Nature, 372, 182, 10.1038/372182a0
Kubota, 2000, Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia, Diabetes, 49, 1880, 10.2337/diabetes.49.11.1880
Terauchi, 2002, Impact of genetic background and ablation of IRS-3 on IRS-2 knockout mice, J Biol Chem
Ueki, 2002, Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase, Proc Natl Acad Sci U S A, 99, 419, 10.1073/pnas.012581799
Fruman, 2000, Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha, Nat Genet, 26, 379, 10.1038/81715
Mauvais-Jarvis, 2002, Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance, Clin Endocrinol (Oxf), 57, 1, 10.1046/j.1365-2265.2002.01563.x
Cho, 2001, Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice, J Biol Chem, 276, 38349, 10.1074/jbc.C100462200
Stenbit, 1997, GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes, Nat Med, 3, 1096, 10.1038/nm1097-1096
Hotamisligil, 1993, Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance, Science, 259, 87, 10.1126/science.7678183
Shoelson, 2003, Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance, Int J Obes Relat Metab Disord, 27, S49, 10.1038/sj.ijo.0802501
Yuan, 2001, Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta, Science, 293, 1673, 10.1126/science.1061620
Weisberg, 2003, Obesity is associated with macrophage accumulation in adipose tissue, J Clin Invest, 112, 1796, 10.1172/JCI200319246
Nguyen, 2007, A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways, J Biol Chem, 282, 35279, 10.1074/jbc.M706762200
Olefsky, 2010, Macrophages, inflammation, and insulin resistance, Annu Rev Physiol, 72, 219, 10.1146/annurev-physiol-021909-135846
Chen, 2005, Diet induction of monocyte chemoattractant protein-1 and its impact on obesity, Obes Res, 13, 1311, 10.1038/oby.2005.159
Weisberg, 2006, CCR2 modulates inflammatory and metabolic effects of high-fat feeding, J Clin Invest, 116, 115, 10.1172/JCI24335
Hotamisligil, 1995, Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance, J Clin Invest, 95, 2409, 10.1172/JCI117936
Hotamisligil, 1994, Tumor necrosis factor alpha: a key component of the obesity-diabetes link, Diabetes, 43, 1271, 10.2337/diabetes.43.11.1271
Hirosumi, 2002, A central role for JNK in obesity and insulin resistance, Nature, 420, 333, 10.1038/nature01137
Konner, 2010, Toll-like receptors: linking inflammation to metabolism, Trends Endocrinol Metab, 22, 16, 10.1016/j.tem.2010.08.007
Kumar, 2009, Toll-like receptors and innate immunity, Biochem Biophys Res Commun, 388, 621, 10.1016/j.bbrc.2009.08.062
Schaeffler, 2009, Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity, Immunology, 126, 233, 10.1111/j.1365-2567.2008.02892.x
Senn, 2006, Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes, J Biol Chem, 281, 26865, 10.1074/jbc.M513304200
Shi, 2006, TLR4 links innate immunity and fatty acid-induced insulin resistance, J Clin Invest, 116, 3015, 10.1172/JCI28898
Reyna, 2008, Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects, Diabetes, 57, 2595, 10.2337/db08-0038
Sanchez-Lasheras, 2010, Integrative neurobiology of energy homeostasis-neurocircuits, signals and mediators, Front Neuroendocrinol, 31, 4, 10.1016/j.yfrne.2009.08.002
Sandoval, 2008, The integrative role of CNS fuel-sensing mechanisms in energy balance and glucose regulation, Annu Rev Physiol, 70, 513, 10.1146/annurev.physiol.70.120806.095256
Escriva, 2007, Effect of age and moderate food restriction on insulin sensitivity in Wistar rats: role of adiposity, J Endocrinol, 194, 131, 10.1677/joe.1.07043
García-San Frutos, 2007, Impaired central insulin response in aged Wistar rats: role of adiposity, Endocrinology, 148, 5238, 10.1210/en.2007-0543
De Souza, 2005, Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus, Endocrinology, 146, 4192, 10.1210/en.2004-1520
Posey, 2009, Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet, Am J Physiol Endocrinol Metab, 296, E1003, 10.1152/ajpendo.90377.2008
Plum, 2006, Central insulin action in energy and glucose homeostasis, J Clin Invest, 116, 1761, 10.1172/JCI29063
Zhang, 2008, Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity, Cell, 135, 61, 10.1016/j.cell.2008.07.043
Ozcan, 2009, Endoplasmic reticulum stress plays a central role in development of leptin resistance, Cell Metab, 9, 35, 10.1016/j.cmet.2008.12.004
Nakatani, 2005, Involvement of endoplasmic reticulum stress in insulin resistance and diabetes, J Biol Chem, 280, 847, 10.1074/jbc.M411860200
Ozcan, 2004, Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes, Science, 306, 457, 10.1126/science.1103160
Lowell, 2005, Mitochondrial dysfunction and type 2 diabetes, Science, 307, 384, 10.1126/science.1104343
Mootha, 2003, PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat Genet, 34, 267, 10.1038/ng1180
Petersen, 2003, Mitochondrial dysfunction in the elderly: possible role in insulin resistance, Science, 300, 1140, 10.1126/science.1082889
Lin, 2005, The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species, J Biol Chem, 280, 4617, 10.1074/jbc.M411863200
Evans, 2003, Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?, Diabetes, 52, 1, 10.2337/diabetes.52.1.1
Bloch-Damti, 2006, Differential effects of IRS1 phosphorylated on Ser307 or Ser632 in the induction of insulin resistance by oxidative stress, Diabetologia, 49, 2463, 10.1007/s00125-006-0349-6
Frank, 2005, The role of reactive oxygen species in insulin signaling in the vasculature, Antioxid Redox Signal, 7, 1053, 10.1089/ars.2005.7.1053
Kim, 2008, Role of mitochondrial dysfunction in insulin resistance, Circ Res, 102, 401, 10.1161/CIRCRESAHA.107.165472
Turner, 2008, Is mitochondrial dysfunction a cause of insulin resistance?, Trends Endocrinol Metab, 19, 324, 10.1016/j.tem.2008.08.001
Mogensen, 2007, Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes, Diabetes, 56, 1592, 10.2337/db06-0981
Patti, 2003, Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1, Proc Natl Acad Sci U S A, 100, 8466, 10.1073/pnas.1032913100
Ek, 2001, Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus, Diabetologia, 44, 2220, 10.1007/s001250100032
Hara, 2002, A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes, Diabetologia, 45, 740, 10.1007/s00125-002-0803-z
Meirhaeghe, 2003, Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo, Biochem J, 373, 155, 10.1042/bj20030200
Lelliott, 2006, Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance, PLoS Biol, 4, e369, 10.1371/journal.pbio.0040369
Nagai, 2009, The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance, Cell Metab, 9, 252, 10.1016/j.cmet.2009.01.011
Kopecky, 1996, Reduction of dietary obesity in aP2-Ucp transgenic mice: mechanism and adipose tissue morphology, Am J Physiol, 270, E776
Clapham, 2000, Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean, Nature, 406, 415, 10.1038/35019082
Unger, 2003, Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome, Endocrinology, 144, 5159, 10.1210/en.2003-0870
Unger, 2000, Lipotoxic diseases of nonadipose tissues in obesity, Int J Obes Relat Metab Disord, 24, S28, 10.1038/sj.ijo.0801498
Virtue, 2008, It's not how fat you are, it's what you do with it that counts, PLoS Biol, 6, e237, 10.1371/journal.pbio.0060237
Vidal-Puig, 2010, Special issue on lipotoxicity, Biochim Biophys Acta, 1801, 207, 10.1016/j.bbalip.2009.12.010
Moller, 2000, Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes, Trends Endocrinol Metab, 11, 212, 10.1016/S1043-2760(00)00272-1
Maeda, 2002, Diet-induced insulin resistance in mice lacking adiponectin/ACRP30, Nat Med, 8, 731, 10.1038/nm724
Knowler, 2002, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med, 346, 393, 10.1056/NEJMoa012512
Bruce, 2006, Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content, Am J Physiol Endocrinol Metab, 291, E99, 10.1152/ajpendo.00587.2005
Duncan, 2003, Exercise training, without weight loss, increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults, Diabetes Care, 26, 557, 10.2337/diacare.26.3.557
Liu, 2007, Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance, J Clin Invest, 117, 1679, 10.1172/JCI30565
Yamaguchi, 2007, Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis, Hepatology, 45, 1366, 10.1002/hep.21655
Sewter, 2002, PPARgamma and the thiazolidinediones: molecular basis for a treatment of “Syndrome X”?, Diabetes Obes Metab, 4, 239, 10.1046/j.1463-1326.2002.00187.x
Koutnikova, 2003, Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice, Proc Natl Acad Sci U S A, 100, 14457, 10.1073/pnas.2336090100
He, 2003, Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle, Proc Natl Acad Sci U S A, 100, 15712, 10.1073/pnas.2536828100
Odegaard, 2007, Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance, Nature, 447, 1116, 10.1038/nature05894
Odegaard, 2008, Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance, Cell Metab, 7, 496, 10.1016/j.cmet.2008.04.003
Hevener, 2007, Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones, J Clin Invest, 117, 1658, 10.1172/JCI31561
Werman, 1997, Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin, J Biol Chem, 272, 20230, 10.1074/jbc.272.32.20230
Ren, 2002, PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis, Genes Dev, 16, 27, 10.1101/gad.953802
Vidal-Puig, 1997, Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids, J Clin Invest, 99, 2416, 10.1172/JCI119424
Medina-Gómez, 2005, The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoform, Diabetes, 54, 1706, 10.2337/diabetes.54.6.1706
Zhang, 2004, Selective disruption of PPAR{gamma}2 impairs the development of adipose tissue and insulin sensitivity, Proc Natl Acad Sci U S A, 101, 10703, 10.1073/pnas.0403652101
Medina-Gómez, 2007, PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism, PLoS Genet, 3, e64, 10.1371/journal.pgen.0030064
Medina-Gómez, 2009, Adaptation and failure of pancreatic beta cells in murine models with different degrees of metabolic syndrome, Dis Model Mech, 2, 582, 10.1242/dmm.003251
Schipper, 2008, Regional anatomic and age effects on cell function of human adipose-derived stem cells, Ann Plast Surg, 60, 538, 10.1097/SAP.0b013e3181723bbe
Slawik, 2007, Adipose tissue expandability and the metabolic syndrome, Genes Nutr, 2, 41, 10.1007/s12263-007-0014-9
Tchkonia, 2007, Increased TNFalpha and CCAAT/enhancer-binding protein homologous protein with aging predispose preadipocytes to resist adipogenesis, Am J Physiol Endocrinol Metab, 293, E1810, 10.1152/ajpendo.00295.2007
Barroso, 1999, Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension, Nature, 402, 880, 10.1038/47254
Gray, 2006, Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice, Diabetes, 55, 2669, 10.2337/db06-0389
Marx, 1998, Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro, Am J Pathol, 153, 17, 10.1016/S0002-9440(10)65540-X
Ricote, 1998, Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein, Proc Natl Acad Sci U S A, 95, 7614, 10.1073/pnas.95.13.7614